europabio-logoeuropabio-logoeuropabio-logoeuropabio-logo
  • About us
    • Who we are
      • Governance
      • Staff
      • Vacancies
    • What we do
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Cell & Gene Therapies
      • Medicines For Rare Diseases And Children
      • Regulatory Efficiency
      • Biosimilars & Public Procurement
      • Data & Digital
      • Patient Bio-Forum
    • Industrial Biotechnology Council
      • Food, Feed & Nutrition
      • Circular Bioeconomy
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
  • Activities
    • 25 Years of Innovation
    • EFIB 2022
    • European Biotech Week
  • Events
  • Newsroom
    • News & Publications
    • Library
Become a member
✕

EuropaBio comments on the Circular Economy Action Plan

20/01/2020
OTHER
IB1

EuropaBio comments on the Circular Economy Action Plan

EuropaBio welcomes the foreseen new Circular Economy Action Plan and the plan to publish it with the Industrial Strategy. Industrial biotechnology is a central pillar of innovation in Europe and one of Europe’s Key Enabling Technologies (KETs). It enables development of smarter, more sustainable products and processes, based on renewable raw materials, which make better use of natural resources, adding value in the process and helping to reduce GHG emissions.

Europe needs strong policy signals, measures and incentives, consolidated through its circular economy strategy, in order to engage industry in the creation of smarter products, processes and partnerships. It is important to ensure the development of a coherent, holistic, supportive policy for the circular economy and for bio-based industries along the value-chain and integrate bioeconomy and circular economy throughout EU policies. Biorefineries, where industrial biotechnology helps convert renewable feedstocks (which can include municipal solid waste, agricultural and forestry waste) into everyday products, are at the centre of the circular economy. The biorefinery model has an important role to play in contributing to ‘zero waste’ objectives. It will also be important to further explore the efficient use of novel biomass and future potential wastes and residues as important resources for developing the bioeconomy.

With industrial biotechnology also other materials can be recovered from organic wastes (lg. carbon or phosphates) and from sludges in biorefineries. With a view to the commercialisation of innovative bio-based products produced in biorefineries, it will be important to have ‘end of waste’ certification and standards in place.

We believe that the bioeconomy should be included in the future EU Circular Economy Action Plan, since the combination of both could boost the achievement of EU ambitions in fields such as climate, resource efficiency and waste.

Bio-based plastics, produced from biomass, help to decrease our dependence on fossil carbon resources and can offer significant CO2 emissions savings. Biodegradable and compostable plastics are designed for specific applications where recycling is not an option when for example items are soiled, and can also offer a key advantage when it comes to the logistics of bio-waste recycling from households. According to the revised Waste Framework Directive, separate collection of bio-waste will be mandatory by end 2023, and thus it is expected that there will be more waste to be efficiently processed or recycled organically, thanks to home or industrial composting systems.

However, we are concerned the generic definition of "biodegradable" can be confusing. Currently, Directive 94/62/EC established the principle of ‘organic recycling’, which makes use of biodegradability of packaging. However, in points 3c and 3d of Annex II with the definitions of essential requirements a differentiation is made between recoverable packaging in the form of compost (3c) and biodegradable packaging (3d), which can generate the erroneous idea that ‘biodegradable packaging’ is different from ‘compostable packaging’. The corresponding harmonised standard EN 13432 requires conformity to the essential requirements for packaging with regard to biodegradable packaging recoverable in the form of compost in accordance with the European Directive. Therefore, clear definitions in the legislation are important.

In relation to forthcoming initiatives on packaging and waste, we believe that the benefits of using renewable resources for the manufacturing of packaging should also be reflected and equally promoted compared to recycled content.

EuropaBio welcomes the intention to address enabling conditions, such as innovation and investment opportunities for circular business models and enabling technologies. Furthermore, EuropaBio supports the continuation of an ambitious public-private partnership on circular bio-based industries, building on the BBI JU’s successes.

EuropaBio comments on the Circular Economy Action Plan


Download
Share
Alexandra Simionca
Alexandra Simionca

Related posts

01/02/2023

Joint Statement: The Data Act is a leap into the unknown


Read more
16/01/2023

SwiftPharma joins EuropaBio: pioneering sustainable, scalable and affordable plant-made therapeutic proteins


Read more
19/12/2022

EuropaBio sat down with new member Association of Biotechnological Companies Bioforum, to find out how they champion biotech in central and eastern Europe


Read more
19/12/2022

The Association of Biotechnological Companies Bioforum joins EuropaBio: representing Polish biotech at European legislative fora and involving Polish companies in the debate about the future of the industry


Read more

Important links

  • Delivering Europe’s ambitions in rare disease
  • Joint Statement: The Data Act is a leap into the unknown

Categories in our Newsroom

Subscribe for our newsletter

Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe
EuropaBio-Logo-White

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 2600 biotech companies, 2300 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2023 Europabio. All Rights Reserved. Designed by EYAS
Become a member
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkLegal & Cookies